Form 4: Zai Lab Executive Rafael Amado Reports Stock Transactions
SEC Form 4 Filing
Rafael Amado, a Zai Lab executive, reports the acquisition and disposal of American Depositary Shares (ADS) related to vesting Restricted Share Units (RSUs).
Summary
- On April 3, 2025, Rafael Amado, President, Head of Global Oncology Research and Development at Zai Lab Ltd, acquired 5,391 American Depositary Shares (ADS) upon the vesting of Restricted Share Units (RSUs).
- On April 4, 2025, Amado disposed of 3,029 ADSs at a price of $33.108 per ADS to cover taxes related to the vesting of the RSUs.
- Following these transactions, Amado directly owns 45,178 ADSs and 10,782 Restricted Share Units.
Sentiment
Score: 5
Explanation: The document reflects routine transactions related to executive compensation, indicating a neutral sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies like Zai Lab. It provides transparency to investors regarding insider transactions.
Comparison to Industry Standards
- Executive compensation packages including RSUs are standard practice in the biotech industry.
- Companies like BeiGene and Legend Biotech also utilize similar equity-based compensation strategies.
- The vesting schedules and tax-related sales are typical components of these arrangements.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding executive stock ownership.
- The sale of shares to cover taxes has a minor impact on the overall market supply of Zai Lab's ADSs.
Key Dates
| Date | Description |
|---|---|
| 04/03/2024 | First anniversary of RSU grant date; RSU vesting begins in equal annual installments over four years. |
| 04/03/2025 | Date of RSU vesting and acquisition of 5,391 ADSs. |
| 04/04/2025 | Date of sale of 3,029 ADSs at $33.108 to cover taxes. |
| 04/07/2025 | Date of signature on the Form 4 filing. |
Keywords
Zai Lab, Rafael Amado, ADS, American Depositary Shares, RSU, Restricted Share Units, Form 4, Beneficial Ownership, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.